Metagenomi Accounts Payable

The latest accounts payable for MGX is $2.6M as of June 2026. That compares with $2.9M in the prior-year period — down 10.0% year over year. Investors often review this figure alongside Metagenomi's historical trend and sector peers before judging valuation or financial health.

Over the past year, MGX's accounts payable moved from $2.9M to $2.6M — a 10.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Metagenomi's operating scale or balance-sheet position.

A accounts payable figure of $2.6M for MGX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting MGX's accounts payable ($2.6M), review year-over-year change from $2.9M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.